Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutr Metab Cardiovasc Dis ; 25(1): 52-9, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25240692

RESUMEN

BACKGROUND AND AIMS: Little is known about the effect of various dietary fatty acids on pro- and anti-inflammatory processes. We investigated the effect of 5 oils containing various amounts of alpha-linolenic acid (ALA), linoleic acid (LA), oleic acid (OA) and docosahexaenoic acid (DHA) on plasma inflammatory biomarkers and expression levels of key inflammatory genes and transcription factors in whole blood cells. METHODS AND RESULTS: In a randomized, crossover controlled nutrition intervention, 114 adult men and women with abdominal obesity and at least one other criterion for the metabolic syndrome consumed 5 experimental isoenergetic diets for 4 weeks each, separated by 4-week washout periods. Each diet provided 60 g/3000 kcal of different oils: 1) control corn/safflower oil blend (CornSaff; LA-rich), 2) flax/safflower oil blend (FlaxSaff; ALA-rich), 3) conventional canola oil (Canola; OA-rich), 4) high oleic canola oil (CanolaOleic; highest OA content), 5) DHA-enriched high oleic canola oil (CanolaDHA; OA- and DHA-rich). Gene expression in whole blood cells was assessed in a subset of 62 subjects. CanolaDHA increased plasma adiponectin concentrations compared with the control CornSaff oil treatment (+4.5%, P = 0.04) and FlaxSaff (+6.9%, P = 0.0008). CanolaDHA also reduced relative expression levels of interleukin (IL)1B compared with CornSaff and Canola (-11% and -13%, respectively, both P = 0.03). High-sensitivity C-reactive protein concentrations were lower after Canola than after FlaxSaff (-17.8%, P = 0.047). CONCLUSION: DHA-enriched canola oil exerts anti-inflammatory effects compared with polyunsaturated fatty acids from plant sources.


Asunto(s)
Adiponectina/agonistas , Antiinflamatorios no Esteroideos/uso terapéutico , Ácidos Docosahexaenoicos/uso terapéutico , Ácidos Grasos Monoinsaturados/uso terapéutico , Mediadores de Inflamación/antagonistas & inhibidores , Síndrome Metabólico/prevención & control , Obesidad Abdominal/dietoterapia , Adiponectina/sangre , Adulto , Anciano , Antiinflamatorios no Esteroideos/análisis , Antiinflamatorios no Esteroideos/química , Biomarcadores/sangre , Biomarcadores/metabolismo , Células Sanguíneas/inmunología , Células Sanguíneas/metabolismo , Índice de Masa Corporal , Canadá/epidemiología , Estudios Cruzados , Ácidos Docosahexaenoicos/análisis , Método Doble Ciego , Ácidos Grasos Monoinsaturados/química , Femenino , Alimentos Fortificados , Regulación de la Expresión Génica , Humanos , Mediadores de Inflamación/sangre , Mediadores de Inflamación/metabolismo , Masculino , Síndrome Metabólico/epidemiología , Síndrome Metabólico/etiología , Persona de Mediana Edad , Obesidad Abdominal/inmunología , Obesidad Abdominal/metabolismo , Obesidad Abdominal/fisiopatología , Pennsylvania/epidemiología , Aceite de Brassica napus , Riesgo , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA